Labiotech.eu

News and Trends 18 Apr 2017

Patent Eligibility: How to Tell if your Life Science Invention is Patentable

So you have an invention, but can you protect it with a patent? This primer will teach you about the criteria, from non-obviousness to inventiveness. How do we define “patent eligibility“? Broadly, the term means that an invention falls within a category of inventions for which the patent laws provide patent protection in general. Inventions […]

April 18, 2017 - 5 minutesmins - By External Contributor

Patrick Baeuerle Successful German Biotech Leader

Interview 17 Apr 2017

Meet One of the Most Successful German Biotech Leaders Ever

Patrick Baeuerle is the German biotech leader I wanted to interview the most (besides Simon Moroney from MorphoSys, who came to our Meetup in Munich last week). Patrick has explored and succeeded in just about every area of life sciences, be it as a highly cited academic researcher, a professor at Freiburg University, head of drug […]

April 17, 2017 - 6 minutesmins - By Philip Hemme

Inside Labiotech 14 Apr 2017

Why is Ingmar Hoerr, Co-Founder & CEO of CureVac, reading Labiotech.eu?

Leaders & Readers: I had a chat with Ingmar Hoerr about why he reads Labiotech.eu. He is the co-founder and CEO of CureVac, one of the most successful European biotechs. This interview has just been lightly edited for grammar. Why do you read Labiotech.eu, and how does it help you in your job? I really like the […]

April 14, 2017 - 2 minutesmins - By Editorial Team

Startup Scout 14 Apr 2017

This Norwegian Biotech Aims to Unlock the Full Potential of Cancer Drugs

This week we visited the Norwegian PCI Biotech. Based in Oslo, this company has developed a light-sensitive technology, which allows to activate cancer drugs at specific sites of the body by targeted illumination. Mission: PCI Biotech focuses on the development of new therapies for the treatment of cancer based on its photochemical internalisation (PCI) technology. The PCI technology consists of a photosensitising […]

April 14, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 13 Apr 2017

Next-Gen Cancer Antibody Technology from Germany enters the Clinic

Apogenix’ partner AbbVie has started the first clinical trial for an immuno-oncology candidate with the potential to outperform antibody therapy. The German biotech Apogenix has announced that its partner AbbVie has initiated a Phase I trial testing its next-generation immuno-oncology technology in patients suffering from solid tumors, non-Hodgkin’s lymphoma (NHL) and acute myeloid leukemia (AML). The candidate […]

April 13, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Transgene Pexa Vec Oncolytic Virus Vaccine

News and Trends 13 Apr 2017

French Oncolytic Virus Vaccine for Breast Cancer enters Phase II

After positive results in Phase I, Transgene has started Phase II with Pexa-Vec in combination with chemotherapy to treat breast cancer and sarcoma. After years of financial instability, Transgene is stepping up its game in cancer immunotherapies. Last year, its first Phase III trial and a deal with Merck and Pfizer brought the hopes of investors […]

April 13, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

university ghent grassoline grass biofuel

News and Trends 13 Apr 2017

Belgian Research takes first steps to make Biofuel out of Grass

Researchers from the University of Ghent are using bacteria to turn grass into chemicals for bioplastics and biofuel. Could this process be scaled up to fuel planes? A grass bioconversion project is being developed at the Centre for Microbial Ecology and Technology (CMET) of the University of Ghent, and it has recently taken an important step forward. […]

April 13, 2017 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 13 Apr 2017

Coming from Behind: How Italy is Revamping its Biotech Industry

Italy’s biotech industry lags behind in Europe, but the situation is starting to change with coordinated efforts in research, finance and organization. While ‘European biotech’ brings to mind France, Germany and the UK, Italy is cultivating its own thriving ecosystem. It claims internationally renowned scientific research institutions, including the University of Perugia and the San Raffaele […]

April 13, 2017 - 5 minutesmins - By External Contributor

News and Trends 12 Apr 2017

Swiss Pharma Clears €37M Funding to Develop a New Class of Antibiotics

Swiss Polyphor has closed a €37M (CHF40M) private funding round to finance the development of its most advanced candidate tackling antibiotic resistances. Polyphor is a clinical stage pharma developing a specific class of so called ‘macrocyclic drugs‘, which are chemically defined by a ring structure. The company’s pipeline is covering a broad range of diseases such as […]

April 12, 2017 - 3 minutesmins - By Melanie De Almeida

Interview 12 Apr 2017

Video Interview: How Morphosys Grew Into a Billion-Euro Biotech

At our first, but for sure not last meetup in Munich last Monday, Philip had the pleasure to have a chat with Simon Moroney, CEO and co-founder of the biggest biotech in Germany, Morphosys. Their topics ranged from Morphosys’ current pipeline and previous failures to the immuno-oncology hype and company culture. Morphosys started out with its […]

April 12, 2017 - 2 minutesmins - By Melanie De Almeida

SIRION Biotech cell therapy lentivirus lentiboost

News and Trends 12 Apr 2017

Taking Cell Therapy one Step Further with this Boost Reagent

Cell therapy is revolutionizing medicine, here’s how the latest technology can help overcome the major challenges stopping it from taking over the market. Offering unprecedented possibilities to treat some of the most challenging diseases, cell therapy is stealing the show in the biotech space. Strimvelis, the first hematopoietic stem cell (HSC) gene therapy is already […]

April 12, 2017 - 4 minutesmins - By External Contributor

News and Trends 11 Apr 2017

French Microbiome Startup Gets a Series A Funding Boost to Regulate Appetite

The French biotech startup TargEDys has extended its series A funding initiated in April 2016 by €3.5M to accelerate the development of its pipeline. After raising an initial €5.8M in a series A funding round from big names like Seventure Partners, TargEDys has now raked an additional €3.5M from the Zaluvida group. The company has also appointed Christoph […]

April 11, 2017 - 3 minutesmins - By Melanie De Almeida

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Patent Eligibility: How to Tell if your Life Science Invention is Patentable

Meet One of the Most Successful German Biotech Leaders Ever

Why is Ingmar Hoerr, Co-Founder & CEO of CureVac, reading Labiotech.eu?

This Norwegian Biotech Aims to Unlock the Full Potential of Cancer Drugs

Next-Gen Cancer Antibody Technology from Germany enters the Clinic

French Oncolytic Virus Vaccine for Breast Cancer enters Phase II

Belgian Research takes first steps to make Biofuel out of Grass

Coming from Behind: How Italy is Revamping its Biotech Industry

Swiss Pharma Clears €37M Funding to Develop a New Class of Antibiotics

Video Interview: How Morphosys Grew Into a Billion-Euro Biotech

Taking Cell Therapy one Step Further with this Boost Reagent

French Microbiome Startup Gets a Series A Funding Boost to Regulate Appetite

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!